These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 30529095)

  • 1. Donor one‑carbon metabolism gene single nucleotide polymorphisms predict the susceptibility of cancer recurrence after liver transplantation.
    Wang C; Lu D; Ling Q; Chen J; Liu Z; Guo H; Xu X; Zheng S
    Gene; 2019 Mar; 689():97-101. PubMed ID: 30529095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The MTHFR polymorphism affect the susceptibility of HCC and the prognosis of HCC liver transplantation.
    Wang C; Xie H; Lu D; Ling Q; Jin P; Li H; Zhuang R; Xu X; Zheng S
    Clin Transl Oncol; 2018 Apr; 20(4):448-456. PubMed ID: 29185200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Donor Polymorphisms of Toll-like Receptor 4 rs1927914 Associated with the Risk of Hepatocellular Carcinoma Recurrence Following Liver Transplantation.
    Shi G; Wang C; Zhang P; Ji L; Xu S; Tan X; Li H
    Arch Med Res; 2017 Aug; 48(6):553-560. PubMed ID: 29221801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Donor interleukin 6 gene polymorphisms predict the recurrence of hepatocellular carcinoma after liver transplantation.
    Chen D; Liu S; Chen S; Wang Z; Wu Z; Ma K; Fan J; Peng Z
    Int J Clin Oncol; 2016 Dec; 21(6):1111-1119. PubMed ID: 27368337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association between donor genetic variations in one-carbon metabolism pathway genes and hepatitis B recurrence after liver transplantation.
    Lu D; Zhuo J; Yang M; Wang C; Pan L; Xie H; Xu X; Zheng S
    Gene; 2018 Jul; 663():121-125. PubMed ID: 29627528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Donor miR-196a-2 polymorphism is associated with hepatocellular carcinoma recurrence after liver transplantation in a Han Chinese population.
    Xu X; Ling Q; Wang J; Xie H; Wei X; Lu D; Hu Q; Zhang X; Wu L; Zhou L; Zheng S
    Int J Cancer; 2016 Feb; 138(3):620-9. PubMed ID: 26365437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between donor and recipient smoothened gene polymorphisms and the risk of hepatocellular carcinoma recurrence following orthotopic liver transplantation in a Han Chinese population.
    Wang P; Song W; Li H; Wang C; Shi B; Guo W; Zhong L
    Tumour Biol; 2015 Sep; 36(10):7807-15. PubMed ID: 25944162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recipient C6 rs9200 genotype is associated with hepatocellular carcinoma recurrence after orthotopic liver transplantation in a Han Chinese population.
    Wang Z; Liao J; Wu S; Li C; Fan J; Peng Z
    Cancer Gene Ther; 2016 Jun; 23(6):157-61. PubMed ID: 27173880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of association between genetic polymorphisms in cytokine genes and tumor recurrence in patients with hepatocellular carcinoma undergoing transplantation.
    Wu LM; Zhou L; Xu J; Wei BJ; Cheng J; Xu X; Xi B; Xie HY; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2013 Feb; 12(1):54-9. PubMed ID: 23392799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recipient C7 rs9292795 genotype and the risk of hepatocellular carcinoma recurrence after orthotopic liver transplantation in a Han Chinese population.
    Jiang Z; Jiang Q; Fang X; Wang P; Que W; Li H; Yu Y; Liu X; Wang C; Zhong L
    BMC Cancer; 2021 May; 21(1):521. PubMed ID: 33964921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic variations in the one-carbon metabolism pathway genes and susceptibility to hepatocellular carcinoma risk: a case-control study.
    Zhang H; Liu C; Han YC; Ma Z; Zhang H; Ma Y; Liu X
    Tumour Biol; 2015 Feb; 36(2):997-1002. PubMed ID: 25318605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single nucleotide polymorphisms in the metastasis-associated in colon cancer-1 gene predict the recurrence of hepatocellular carcinoma after transplantation.
    Zheng Z; Gao S; Yang Z; Xie H; Zhang C; Lin B; Wu L; Zheng S; Zhou L
    Int J Med Sci; 2014; 11(2):142-50. PubMed ID: 24465159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ALDH1L1 variant rs2276724 and mRNA expression predict post-operative clinical outcomes and are associated with TP53 expression in HBV-related hepatocellular carcinoma.
    Zhu G; Liao X; Han C; Liu X; Yu L; Qin W; Lu S; Su H; Chen Z; Liu Z; Liang Y; Huang J; Yu T; Yang C; Huang K; Shang L; Ye X; Li L; Qin X; Xiao K; Peng M; Peng T
    Oncol Rep; 2017 Sep; 38(3):1451-1463. PubMed ID: 28714006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between Recipient IL-15 Genetic Variant and the Prognosis of HBV-Related Hepatocellular Carcinoma after Liver Transplantation.
    Zhang T; Liu Y; Peng X; Fan J; Peng Z
    Dis Markers; 2017; 2017():1754696. PubMed ID: 29162948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single nucleotide polymorphisms of XRCC3 gene in hepatocellular carcinoma - relationship with clinicopathological features.
    Avadanei ER; Giusca SE; Negura L; Caruntu ID
    Pol J Pathol; 2018; 69(1):73-81. PubMed ID: 29895130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early-phase circulating miRNAs predict tumor recurrence and survival of hepatocellular carcinoma patients after liver transplantation.
    Ng KT; Lo CM; Wong N; Li CX; Qi X; Liu XB; Geng W; Yeung OW; Ma YY; Chan SC; Man K
    Oncotarget; 2016 Apr; 7(15):19824-39. PubMed ID: 26918346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and prognostic significance of insulin‑like growth factor-2 receptor in human hepatocellular carcinoma and the influence of transarterial chemoembolization.
    Lautem A; Simon F; Hoppe-Lotichius M; Mittler J; Vollmar J; Schad A; Düber C; Galle PR; Otto G; Zimmermann T; Lang H
    Oncol Rep; 2019 Apr; 41(4):2299-2310. PubMed ID: 30720132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MDR1 gene polymorphism correlated with pathological characteristics and prognosis in patients with primary hepatocellular carcinoma receiving interventional therapy.
    Hu W; Huang S; Dong L; Yu C; Li C; Zhang J
    Anticancer Drugs; 2019 Mar; 30(3):233-240. PubMed ID: 30779721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The RFC1 80G>A, among Common One-Carbon Polymorphisms, Relates to Survival Rate According to DNA Global Methylation in Primary Liver Cancers.
    Moruzzi S; Udali S; Ruzzenente A; Guglielmi A; Guarini P; Martinelli N; Conci S; Mazzi F; Pattini P; Tammen SA; Olivieri O; Pizzolo F; Choi SW; Friso S
    PLoS One; 2016; 11(12):e0167534. PubMed ID: 27936032
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    de la Fuente S; Citores MJ; Lucena JL; Muñoz P; Cuervas-Mons V
    Biomark Med; 2019 Aug; 13(12):995-1004. PubMed ID: 31317790
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.